Bogart Wealth LLC’s Pliant Therapeutics PLRX Stock Holding History

Bogart Wealth LLC’s Portfolio PLRX Stock Details PLRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-29	Closed	-$771	–	1099
2023 Q1	$771	Buy	+29	New	+$826	﹤0.01%	1005

Other funds holding PLRX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

TGI

TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Bogart Wealth LLC's PLRX Position: Q2 2023 in Review

Bogart Wealth LLC sold out of Pliant Therapeutics (PLRX) in Q2 2023, closing a stake of 29 shares — an estimated $771 sold.

Bogart Wealth LLC first reported a position in PLRX in Q1 2023 and held it in 1 quarter. The position peaked at $771 in Q1 2023. 144 funds tracked by Wall St. Rank hold PLRX as of Q2 2023.

Bogart Wealth LLC reported no remaining Pliant Therapeutics position as of Q2 2023 after selling out during the quarter.
Bogart Wealth LLC sold 29 Pliant Therapeutics shares in Q2 2023, an estimated $771.
Bogart Wealth LLC first reported a position in Pliant Therapeutics in Q1 2023 and held it in 1 quarter.
Bogart Wealth LLC's Pliant Therapeutics position peaked at $771 in Q1 2023.
144 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q2 2023.

Based on Bogart Wealth LLC's 13F filing for Q2 2023, filed 31 Jul 2023.